TrianglePUBLICATIONS · 28533223
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR(+)/HER2(-) Metastatic Breast Cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Cancer Res
- Publication date
- 2017 Sep 1
- First author
- Dickler MN
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Clin Cancer Res. 2018 Nov 1;24(21):5485. doi: 10.1158/1078-0432.CCR-18-3193.
- note
- Source null
- related pmid
- 30385657
- relationship
- Erratum in
Authors and identifiers
- name
- Dickler MN
- type
- Author
- name
- Tolaney SM
- type
- Author
- name
- Rugo HS
- type
- Author
- name
- Cortés J
- type
- Author
- name
- Diéras V
- type
- Author
- name
- Patt D
- type
- Author
- name
- Wildiers H
- type
- Author
- name
- Hudis CA
- type
- Author
- name
- O'Shaughnessy J
- type
- Author
- name
- Zamora E
- type
- Author
- name
- Yardley DA
- type
- Author
- name
- Frenzel M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Dickler MN
- type
- Author
- name
- Tolaney SM
- type
- Author
- name
- Rugo HS
- type
- Author
- name
- Cortés J
- type
- Author
- name
- Diéras V
- type
- Author
- name
- Patt D
- type
- Author
- name
- Wildiers H
- type
- Author
- name
- Hudis CA
- type
- Author
- name
- O'Shaughnessy J
- type
- Author
- name
- Zamora E
- type
- Author
- name
- Yardley DA
- type
- Author
- name
- Frenzel M
- type
- Author
- bibliography ids
- nci-bib-18a692c1215c35075532aaf7
- book metadata
- content sha256
- eb39601a6fa5fa94556c8d01bdc6321d578090c1d52cd50b5d427765b22c10b8
- document type
- citation
- dois
- 10.1158/1078-0432.CCR-17-0754
- electronic publication date
- display
- 2017 May 22
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28533223
- immutable id
- pubmed:28533223@eb39601a6fa5fa94556c8d01bdc6321d578090c1d52cd50b5d427765b22c10b8
- journal
- abbreviation
- Clin Cancer Res
- issn electronic
- 1557-3265
- issn print
- 1078-0432
- issue
- 17
- name
- Clinical cancer research : an official journal of the American Association for Cancer Research
- nlm unique id
- 9502500
- pages
- 5218-5224
- volume
- 23
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Clin Cancer Res. 2018 Nov 1;24(21):5485. doi: 10.1158/1078-0432.CCR-18-3193.
- note
- Source null
- related pmid
- 30385657
- relationship
- Erratum in
- outcomes validated
- false
- pmid
- 28533223
- provenance
- batch id
- 1c173f0e18be0c6d461b
- provider
- NCBI PubMed ESummary
- record sha256
- 041f666dd7c36078ad6938804def46aac411503e079fc53c00afd9546e771ebd
- response sha256
- 27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
- retrieved at
- 2026-09-09T23:47:25.975513+00:00
- publication date
- display
- 2017 Sep 1
- precision
- day
- year
- 2017
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR(+)/HER2(-) Metastatic Breast Cancer.
Preserved source evidence · Not medical advice